Healthcare reality of the treatment of the high-risk multiple myeloma in Spain

被引：2
作者：
Hernandez-Rivas, Jose-Angel [1 ,2 ]
Gironella Mesa, Mercedes [3 ,4 ]
机构：
[1] Hosp Univ Infanta Leonor, Serv Hematol & Hemoterapia, Madrid, Spain
[2] Univ Complutense Madrid, Dept Med, Madrid, Spain
[3] Hosp Univ Vail dHebron, Serv Hematol, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
来源：
MEDICINA CLINICA | 2020年 / 154卷 / 08期
关键词：
LENALIDOMIDE PLUS DEXAMETHASONE; TREATMENT STRATEGIES; CONSENSUS; STRATIFICATION; CARFILZOMIB; GUIDELINES; MANAGEMENT; SURVIVAL;
D O I：
10.1016/j.medcli.2019.10.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：315 / 319
页数：5
相关论文
共 50 条
[41]   A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study [J].
Rios-Tamayo, Rafael ;
Soler, Juan Alfons ;
Garcia-Sanchez, Ricarda ;
Persona, Ernesto Perez ;
Arnao, Mario ;
Garcia-Guinon, Antoni ;
Domingo, Abel ;
Gonzalez-Pardo, Miriam ;
de la Rubia, Javier ;
Mateos, Maria Victoria .
HEMATOLOGY, 2023, 28 (01)
[42]   Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis [J].
Scott, Emma C. ;
Hari, Parameswaran ;
Sharma, Manish ;
Le-Rademacher, Jennifer ;
Huang, Jiaxing ;
Vogl, Dan ;
Abidi, Muneer ;
Beitinjaneh, Amer ;
Fung, Henry ;
Ganguly, Siddhartha ;
Hildebrandt, Gerhard ;
Holmberg, Leona ;
Kalaycio, Matt ;
Kumar, Shaji ;
Kyle, Robert ;
Lazarus, Hillard ;
Lee, Cindy ;
Maziarz, Richard T. ;
Meehan, Kenneth ;
Mikhael, Joseph ;
Nishihori, Taiga ;
Ramanathan, Muthalagu ;
Usmani, Saad ;
Tay, Jason ;
Vesole, David ;
Wirk, Baldeep ;
Yared, Jean ;
Savani, Bipin N. ;
Gasparetto, Cristina ;
Krishnan, Amrita ;
Mark, Tomer ;
Nieto, Yago ;
D'Souza, Anita .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) :1893-1899
[43]   Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in Europe [J].
Gaultney, Jennifer G. ;
Ng, Therese W. ;
Uyl-de Groot, Carin A. ;
Sonneveld, Pieter ;
van Beers, Erik H. ;
van Vliet, Martin H. ;
Redekop, William K. .
PHARMACOGENOMICS, 2018, 19 (03) :213-226
[44]   Identifying high-risk multiple myeloma patients: A novel approach using a clonal gene signature [J].
Li, Jian-Rong ;
Wang, Christiana ;
Cheng, Chao .
INTERNATIONAL JOURNAL OF CANCER, 2024, :1684-1695
[45]   High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma [J].
Murakami, H ;
Fujii, H ;
Inaba, T ;
Shimazaki, C ;
Okamoto, S ;
Miwa, A ;
Sawamura, M ;
Abe, M ;
Chou, T ;
Asaoku, H ;
Kitahara, Y ;
Hayashi, K ;
Kosaka, M ;
Togawa, A ;
Takatsuki, K .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) :169-173
[46]   Healthcare costs of multiple myeloma: an Italian study [J].
Koleva, D. ;
Cortelazzo, S. ;
Toldo, C. ;
Garattini, L. .
EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (03) :330-336
[47]   Risk Stratification and Treatment in Smoldering Multiple Myeloma [J].
Lussier, Tyler ;
Schoebe, Natalie ;
Mai, Sabine .
CELLS, 2022, 11 (01)
[48]   Roundtable: How I treat a newly diagnosed patient with high-risk myeloma [J].
Kaufman, Jonathan L. .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, :120-124
[49]   Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma [J].
Zhang, Limei ;
Chen, Shuzhao ;
Huang, Mayan ;
Wang, Weida ;
Liang, Yang ;
Wang, Yun .
ANNALS OF HEMATOLOGY, 2023, 102 (01) :125-132
[50]   Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study [J].
Jakubowiak, A. J. ;
Siegel, D. S. ;
Martin, T. ;
Wang, M. ;
Vij, R. ;
Lonial, S. ;
Trudel, S. ;
Kukreti, V. ;
Bahlis, N. ;
Alsina, M. ;
Chanan-Khan, A. ;
Buadi, F. ;
Reu, F. J. ;
Somlo, G. ;
Zonder, J. ;
Song, K. ;
Stewart, A. K. ;
Stadtmauer, E. ;
Harrison, B. L. ;
Wong, A. F. ;
Orlowski, R. Z. ;
Jagannath, S. .
LEUKEMIA, 2013, 27 (12) :2351-2356
12345